IL6 and COVID-19: Based on this evidence, the potential influential role of NETs and their by-products in COVID-19 pathogenesis and outcome is now rapidly gaining acceptance and has also been considered in treatment approaches in COVID-19 such as anti-IL6 and IL26 therapy (e.g., [5, 43–45]).